Abstract: The present invention relates to the use of a particular type of adipose tissue derived mesenchymal stem cells (AD-MSCs), which exert immunosuppressive properties, in the manufacture of a pharmaceutical composition for the prevention and treatment of the graft-versus-host disease (GVHD) produced after allogeneic hematopoietic stem cell transplantation.
Type:
Application
Filed:
December 7, 2006
Publication date:
June 11, 2009
Applicants:
CELLERIX, S.L., CENTRO DE INVESTIGACIONES ENERGETICAS, MEDIOAMBIENTALES Y TECHNOLOGICAS
Inventors:
Manuel Angel Gonzalez De La Pena, Dirk Buscher, Aitor Beraza Perez, Juan Bueren Roncero, Rosa Maria Yanez Gonzalez, Maria Lamana Luzuriaga